Moderna Covid-19 vaccine gets Phase 2 study green lightMay 8, 2020 - 12:36 AMT PanARMENIAN.Net - The promising coronavirus vaccine developed by Cambridge-based company Moderna was cleared by the FDA for a phase 2 study, a step that will push the much needed vaccine forward, Boston Herald reports. Moderna Therapeutics, a Cambridge, Mass.-based biotech company co-founded by Armenian entrepreneur Noubar Afeyan, shipped the first batches of its Covid-19 vaccine in February. “The imminent Phase 2 study start is a crucial step forward as we continue to advance the clinical development of mRNA-1273, our vaccine candidate against SARS-CoV-2,” said Stephane Bancel, Moderna’s chief executive officer in a press release issued by the company on Thursday. Moderna has a goal of starting a pivotal phase 3 study in the summer and could have its first biologics license application approved as soon as next year, Bancel’s statement said. “We are accelerating manufacturing scale-up and our partnership with Lonza puts us in a position to make and distribute as many vaccine doses of mRNA-1273 as possible, should it prove to be safe and effective,” said Bancel. Top stories Six total incidents have burned 19 old-growth trees. Friday night 8 trees were torched along the beautiful main entrance. The EU does not intend to conduct military exercises with Armenia, Lead Spokesperson for EU Foreign Affairs and Security Policy Peter Stano says. Hikmet Hajiyev has said that there is no place for USAID operation in Azerbaijan any longer. A telephone conversation between Putin and Pashinyan before the CSTO summit is not planned, Peskov says. Partner news | Viva-MTS: Tech solutions to modernize infrastructure of border village The border village has been the focus of Viva-MTS and the Foundation for the Preservation of Wildlife and Cultural Values since 2015. Ucom's fixed network launched in Artashat To mark this occasion, the company has introduced a special offer exclusively for Artashat residents. “By Your Side”: IDBank's new support program for displaced Artsakh citizens IDBank is launching a long-term social support program for forcibly displaced Artsakh residents. The Power of One Dram to benefit Road of Life charity The companies inform that the May beneficiary of The Power of One Dram is the “Road of Life” charitable organization. |